A cause other than paradoxical embolism was usually apparent in patients with recurrent neurologic events.\n\nConclusions\n\nIn
patients with cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device did not offer a greater buy CA3 benefit than medical therapy alone for the prevention of recurrent stroke or TIA. (Funded by NMT Medical; ClinicalTrials.gov number, NCT00201461.)”
“Introduction. Clotting disturbances resulting from chronic renal failure do not remit immediately after successful kidney transplantation (KT’x). Hemorrhagic and thrombotic complications after KTx increase the risk of transplanted kidney loss. The aim of the study was to analyze the influence of clotting system disturbances and applied antithrombotic prophylaxis on the development of hemorrhagic and thrombotic complications among KTx patients in the early postoperative period.\n\nMaterials and methods. Sixty seven KTx patients underwent measurement of plasma activated partial thromboplastin time (APTT); international normalized ratio; fibrinogen AZD7762 solubility dmso and D-dimer concentration; activity of antitrombin III; protein C and S, VIII, IX; and von Willebrand factors, as well as platelet counts.\n\nResults. A perigraft hematoma developed in 25.4% patients, of whom 4.5% required reoperation. Lower antithrombin III
activity (96.2 +/- 27.6 vs 112.3 +/- 17.4, P = .02) on postoperative day (POD) 7 and higher fibrinogen concentration (4.41 +/- 2.03 vs 3.35 +/- 0.87, P = .01) and platelet count (269.8 +/- 117.5 vs 215.8 +/- 64.8, P = .03) on POD 14 were noted in recipients with a hematoma compared to those free of this complication. A perigraft hematoma developed in 57.9% patients undergoing antithrombotic prophylaxis and in 12.5% without this treatment (P = .0002). Among patients receiving unfractionated heparin, we observed extension of APTT on POD 1(45.9 +/- find more 53.2 vs 30.9 +/- 7.5 seconds, P = .04), higher von Willebrand factor activity on POD 7 (348.8 122.2 vs 218.5 +/-
125.5, P = .02), and higher D-dimer concentrations POD 7 and 14 (1662 +/- 894 vs 757 +/- 708, P = .002 and 1614 +/- 1372 vs 672 +/- 532, P = .003, respectively). No significant differences were observed as regards to analyzed parameters between patients receiving low-molecular-weight heparin versus those not receiving antithrombotic prophylaxis.\n\nConclusions. Disturbances in analyzed parameters of hemostasis did not increase the risk of hemorrhagic and thrombotic complications in the early period after KTx. Antithrombotic prophylaxis increases the risk of hemorrhagic complications and should be introduced only for selected renal transplant recipients.”
“Acute bronchiolitis has been associated with an increasing hospitalization rate over the past decades. The aim of this paper was to estimate the impact of home oxygen therapy (HOT) on hospital stay for infants with acute bronchiolitis.